Blockade of both CXCR4 and PD-1 prevents suppression of immune cell function in HCC tumors, enhances immune cell tumor penetration and activation, and ultimately delays HCC progression [26]. This evidence concerns the gene CXCR4 and hepatocellular carcinoma.